D-Limonene Reduces Fibrosis and Inflammation in Liver Cirrhosis Model Study

Recent research has identified D-limonene as a compound with potential therapeutic benefits for liver health, particularly in cases of liver cirrhosis. A study led by Sabbagh and colleagues examined the anti-fibrotic and anti-inflammatory effects of D-limonene in male rats undergoing bile duct ligation, a widely used experimental model for inducing liver damage. The findings suggest that D-limonene may play a role in mitigating the progression of liver fibrosis and inflammation associated with cirrhosis.

The study focused on evaluating how D-limonene impacts key markers of liver health in the bile duct ligation model. Researchers observed reductions in fibrosis and inflammation, which are hallmark features of cirrhosis. These results highlight the compound’s ability to potentially counteract some of the damaging processes involved in chronic liver disease. While further investigation is necessary to determine its applicability to human cases, this research provides insight into the mechanisms through which D-limonene could support liver function under conditions of severe damage.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

Related posts:

New Policy Aims to Reduce Prior Authorizations, Addressing Medication Delays Linked to Health Complications Study Finds Symptom Provocation Before rTMS May Improve Treatment for OCD and Nicotine Dependence High School Student Eden Murphy Awarded Scholarship After Undergoing Two Heart Transplants Fatigue Linked to Neurophysiological Factors and Immune System Disruptions

Author

GOAI